{"id":69029,"date":"2026-03-13T12:12:34","date_gmt":"2026-03-13T12:12:34","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=69029"},"modified":"2026-10-15T10:33:59","modified_gmt":"2026-10-15T10:33:59","slug":"ss-31-elamipretide","status":"publish","type":"product","link":"https:\/\/medsbase.com\/es\/product\/ss-31-elamipretide\/","title":{"rendered":"SS-31 (Elamipretide)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Respuesta r\u00e1pida \u2014 \u00bfQu\u00e9 es SS-31 (Elamipretide)?<\/h3>\n<p style=\"margin: 0;\"><strong>SS-31<\/strong> (tambi\u00e9n llamado <strong>Elamipretide<\/strong> o <strong>Bendavia<\/strong>) es un tetrap\u00e9ptido sint\u00e9tico que se une selectivamente <strong>a la cardiolipina<\/strong> on the inner mitochondrial membrane, stabilizing mitochondrial function under stress. Developed by the Szeto-Schiller lab and now in late-stage clinical development by Stealth BioTherapeutics with FDA orphan-drug designation for rare mitochondrial disease. Supplied in 5\u00a0mg to 50\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Qu\u00e9 obtienes con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/es\/reviews\/\">opiniones de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada pedido est\u00e1 cubierto por nuestra <a href=\"https:\/\/medsbase.com\/es\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 si tu paquete no llega en 20 d\u00edas laborables, lo reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especificaci\u00f3n<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalle<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">736992-21-5<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>32<\/sub>H<sub>49<\/sub>N<sub>9<\/sub>O<sub>5<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">639.80 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Secuencia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">D-Arg-2\u2032,6\u2032-Dmt-Lys-Phe-NH<sub>2<\/sub> (Bendavia, MTP-131)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Polvo liofilizado (o seg\u00fan suministro)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC, COA bajo solicitud)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Almacenamiento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (refrigerador) para stock de trabajo; \u221220 \u00b0C para almacenamiento a largo plazo de viales sin abrir. Reconstituido: 2\u20138 \u00b0C, usar dentro de ~30 d\u00edas. Proteger de la luz. No congelar-descongelar la soluci\u00f3n reconstituida.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidad<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Agua bacteriost\u00e1tica (recomendada) o agua est\u00e9ril para periodos de uso m\u00e1s cortos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>\u00bfQu\u00e9 es SS-31 (Elamipretide)?<\/h2>\n<p><strong>SS-31<\/strong> es un tetrap\u00e9ptido sint\u00e9tico permeable a las c\u00e9lulas (D-Arg-2\u20196'-dimetil-L-Tyr-L-Lys-L-Phe, tambi\u00e9n abreviado <strong>Szeto-Schiller 31<\/strong>) desarrollado por Hazel Szeto y Peter Schiller en el Weill Medical College de Cornell a partir de la d\u00e9cada de 1990. Tambi\u00e9n se conoce por sus nombres de desarrollo farmac\u00e9utico <strong>Elamipretide<\/strong> y <strong>Bendavia<\/strong>, y est\u00e1 siendo desarrollado cl\u00ednicamente por <strong>Stealth BioTherapeutics<\/strong>. Unlike most peptides that bind cell-surface receptors, SS-31 is a <strong>agente dirigido a las mitocondrias<\/strong> que atraviesa las membranas celulares y de los org\u00e1nulos para llegar a la membrana mitocondrial interna, donde se une <strong>a la cardiolipina<\/strong> \u2014 a phospholipid unique to that location. This selective lipid binding underpins its mechanism of action and distinguishes SS-31 from virtually every other peptide. Molecular weight approximately 640\u00a0Da. SS-31 has <strong>designaci\u00f3n de medicamento hu\u00e9rfano por la FDA<\/strong> for primary mitochondrial myopathy and has been the subject of multiple human clinical trials \u2014 placing it further along the clinical development pipeline than most peptides. It is supplied here as a high-purity lyophilized powder <strong>for clinical studies use only<\/strong> (Stealth&#8217;s clinical product is a separate regulated therapeutic). For deeper mechanism, Szeto lab studies history, and clinical-trial context, see our <a href=\"https:\/\/medsbase.com\/es\/ss-31-elamipretide-mitochondrial-guide\/\">SS-31 guide<\/a>. <\/p>\n<h2>Mecanismo de acci\u00f3n \u2014 Estabilizaci\u00f3n mitocondrial dirigida a la cardiolipina<\/h2>\n<p>SS-31&#8217;s mechanism is unique among peptides because its target is a phospholipid, not a receptor protein. Three interconnected effects define its pharmacology:<\/p>\n<ul>\n<li><strong>Uni\u00f3n a la cardiolipina<\/strong> \u2014 El SS-31 se une selectivamente a la cardiolipina en la membrana mitocondrial interna. La cardiolipina es un l\u00edpido caracter\u00edstico que se encuentra casi exclusivamente en esta ubicaci\u00f3n y es esencial para la arquitectura de las crestas (la superficie plegada de la membrana interna donde se agrupan los complejos de la cadena de transporte de electrones). La uni\u00f3n del SS-31 <strong>estabiliza la morfolog\u00eda de las crestas<\/strong> durante situaciones de estr\u00e9s que, de otro modo, causar\u00edan la disrupci\u00f3n de las crestas y la disfunci\u00f3n mitocondrial.<\/li>\n<li><strong>Reducci\u00f3n de ROS y preservaci\u00f3n de la CTE<\/strong> \u2014 by preserving cristae architecture, SS-31 maintains the proper organization of electron-transport-chain complexes, preserving ATP synthesis and reducing electron &#8220;leakage&#8221; that generates reactive oxygen species. In ischemia-reperfusion study models, this translates to reduced oxidative damage and preserved mitochondrial function.<\/li>\n<li><strong>Prevenci\u00f3n de la liberaci\u00f3n de citocromo c<\/strong> \u2014 mitochondrial apoptosis begins with cytochrome c release from the inner membrane space into the cytoplasm. By preserving cristae structure, SS-31 preserves cytochrome c localization and blocks a critical apoptotic trigger. This is central to its cardiac ischemia-reperfusion signal.<\/li>\n<\/ul>\n<p>The practical studies implication: SS-31 is the reference mitochondria-targeted peptide. Where other peptides act at cell-surface receptors, SS-31 acts inside the organelle, preserving mitochondrial function in study models of metabolic stress, ischemia, and aging. <\/p>\n<h2>Published Evidence<\/h2>\n<p>SS-31 is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Primary mitochondrial disease studies<\/strong> \u2014 rare mitochondrial myopathy studies including Barth syndrome; SS-31 has FDA orphan-drug designation for this indication<\/li>\n<li><strong>Cardiac studies<\/strong> \u2014 heart failure, ischemia-reperfusion, cardiomyopathy, and cardiotoxicity rescue studies (Szeto, AAPS J 2014)<\/li>\n<li><strong>Renal studies<\/strong> \u2014 acute kidney injury, ischemia-reperfusion, and chronic kidney disease studies (Birk et al., J Am Soc Nephrol 2013)<\/li>\n<li><strong>Aging studies<\/strong> \u2014 disfunci\u00f3n mitocondrial relacionada con la edad, envejecimiento del m\u00fasculo esquel\u00e9tico (sarcopenia) y marcadores generales de envejecimiento celular<\/li>\n<li><strong>Neuroprotection studies<\/strong> \u2014 ischemic-stroke and neurodegeneration studies where mitochondrial dysfunction is a driver<\/li>\n<li><strong>Sarcopenia studies<\/strong> \u2014 skeletal-muscle mitochondrial function and age-related muscle loss studies<\/li>\n<li><strong>Comparative mitochondrial-agent studies<\/strong> \u2014 en comparaci\u00f3n directa con <a href=\"https:\/\/medsbase.com\/es\/nad\/\">NAD+<\/a> (coenzima mitocondrial) y MitoQ (otro antioxidante dirigido a las mitocondrias) para aislar el mecanismo<\/li>\n<\/ul>\n<p>For broader context on longevity and mitochondrial-compounds see the <a href=\"https:\/\/medsbase.com\/es\/peptides\/\">cat\u00e1logo de p\u00e9ptidos<\/a>. <\/p>\n<h2>Concentraciones y potencias disponibles<\/h2>\n<p>MedsBase dispone de SS-31 (Elamipretida) en los siguientes tama\u00f1os de viales liofilizados:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Potencia del vial<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tama\u00f1os de paquete<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, low-dose rodent work<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, extended rodent studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>50 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Large-scale studies, clinical-trial-matched doses (40 mg\/day), lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The 50\u00a0mg vial size matches the clinical-trial 40 mg\/day dose used in Stealth BioTherapeutics&#8217;s human studies. Preclinical rodent studies typically uses smaller vials matched to 1\u20135 mg\/kg body weight. All strengths are supplied as lyophilized powder at 99%+ HPLC purity. <\/p>\n<h2>Comparativa \u2014 SS-31 frente a otros compuestos mitocondriales\/longevidad<\/h2>\n<p>SS-31 is part of a small but growing class of mitochondria-targeted studies agents. Key comparisons:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">SS-31 (Elamipretide)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">NAD+<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Epital\u00f3n<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Objetivo principal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Cardiolipina (l\u00edpido de la membrana mitocondrial interna)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sirtuinas, enzimas PARP, cadena de transporte de electrones<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Expresi\u00f3n g\u00e9nica, se\u00f1alizaci\u00f3n pineal<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Evidencia mecanicista<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">S\u00f3lida (m\u00faltiples laboratorios, ensayos cl\u00ednicos)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Muy s\u00f3lida (bioqu\u00edmica bien caracterizada)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Grupo reducido (Khavinson)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Estado cl\u00ednico<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">F\u00e1rmaco hu\u00e9rfano de la FDA, fase 3 (s\u00edndrome de Barth)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">No aprobado (uso en terapia intravenosa)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">No aprobado<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Strongest signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Isquemia card\u00edaca, renal, sarcopenia<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Longevidad, energ\u00eda, reparaci\u00f3n del ADN<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tel\u00f3mero, circadiano<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dosis t\u00edpica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5\u201340 mg diarios (cl\u00ednico); 1\u20135 mg\/kg (precl\u00ednico)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">50\u2013100 mg diarios<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">5\u201310 mg SC diarios<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>SS-31 is distinct because it is the only peptide targeting a mitochondrial lipid directly. Users often study it alongside <a href=\"https:\/\/medsbase.com\/es\/nad\/\">NAD+<\/a> (para una cobertura complementaria de la v\u00eda de las sirtuinas) y <a href=\"https:\/\/medsbase.com\/es\/epitalon\/\">Epital\u00f3n<\/a> in multi-pathway longevity protocols. <\/p>\n<h2>Almacenamiento y reconstituci\u00f3n<\/h2>\n<p><strong>Antes de la reconstituci\u00f3n:<\/strong> almacene los viales liofilizados refrigerados a 2\u20138 \u00b0C en su envase original, estables hasta 36 meses. Evite los ciclos de congelaci\u00f3n-descongelaci\u00f3n en el polvo. <strong>Procedimiento de reconstituci\u00f3n:<\/strong> inyectar agua bacteriost\u00e1tica por la pared lateral del vial de p\u00e9ptidos seg\u00fan el cuadro anterior. Agitar suavemente \u2014 no <strong>ajuste<\/strong> sacudir \u2014 y dejar reposar 5\u201310 minutos para su completa disoluci\u00f3n. La soluci\u00f3n debe ser transparente e incolora. <strong>Despu\u00e9s de la reconstituci\u00f3n:<\/strong> Conservar refrigerado a 2\u20138\u00a0\u00b0C y utilizar en un plazo de 30 d\u00edas. No congelar la soluci\u00f3n reconstituida. <\/p>\n<h2 id=\"faqs\">Preguntas frecuentes<\/h2>\n<h3>What is SS-31 used for in studies?<\/h3>\n<p>SS-31 (Elamipretide) is used in studies investigating mitochondrial disease (including Barth syndrome), cardiac ischemia-reperfusion, heart failure, acute kidney injury, chronic kidney disease, age-related mitochondrial dysfunction, sarcopenia, and neuroprotection. It has FDA orphan-drug designation but is <strong>ajuste<\/strong> yet FDA-approved for therapeutic use. Sold here strictly for clinical studies use only. <\/p>\n<h3>How is SS-31 different from other peptides?<\/h3>\n<p>El SS-31 es \u00fanico porque su objetivo es <strong>a la cardiolipina<\/strong> \u2014 a phospholipid on the inner mitochondrial membrane \u2014 not a cell-surface receptor. It is cell-permeable and reaches the mitochondrial matrix to stabilize cristae architecture and preserve electron-transport-chain function. Virtually every other peptide binds receptors on the cell surface. <\/p>\n<h3>What is the typical SS-31 dose?<\/h3>\n<p>Stealth BioTherapeutics&#8217; clinical trials have used 40\u00a0mg SC daily. Preclinical rodent studies typically uses 1\u20135\u00a0mg\/kg body weight daily. A 10\u00a0mg vial reconstituted with 2.0\u00a0mL bacteriostatic water yields 5.0\u00a0mg\/mL \u2014 100 ticks on a U-100 syringe delivers 5\u00a0mg. <\/p>\n<h3>\u00bfEst\u00e1 el SS-31 aprobado por la FDA?<\/h3>\n<p>El SS-31 (Elamipretide) tiene la designaci\u00f3n de medicamento hu\u00e9rfano por la FDA para la miopat\u00eda mitocondrial primaria y se encuentra en desarrollo cl\u00ednico avanzado por Stealth BioTherapeutics. No est\u00e1 <strong>ajuste<\/strong> yet fully FDA-approved. All SS-31 sold by specialist suppliers is for clinical investigation, not the clinical-trial therapeutic product. <\/p>\n<h3>\u00bfQu\u00e9 significa la abreviatura \u201cSS-31\u201d?<\/h3>\n<p>SS-31 significa <strong>compuesto Szeto-Schiller 31<\/strong>, after the Cornell users Hazel Szeto and Peter Schiller who developed the SS-series of mitochondria-targeted peptides in the 1990s and 2000s. The &#8220;31&#8221; is simply the compound number in their synthesis series. The compound was later licensed to Stealth BioTherapeutics and renamed Elamipretide (and Bendavia) for clinical development. <\/p>\n<h3>\u00bfC\u00f3mo se debe almacenar el SS-31?<\/h3>\n<p>Viales liofilizados: refrigerados a 2\u20138\u00a0\u00b0C en el envase original, estable hasta 36 meses. Soluci\u00f3n reconstituida: refrigerada a 2\u20138\u00a0\u00b0C, utilizar en un plazo de 30 d\u00edas. No congelar la soluci\u00f3n reconstituida. <\/p>\n<h3>\u00bfC\u00f3mo reconstituyo el SS-31?<\/h3>\n<p>Sigue la tabla de reconstituci\u00f3n anterior. A\u00f1ade agua bacteriost\u00e1tica por la pared lateral del vial, agita suavemente y deja reposar entre 5 y 10 minutos para una disoluci\u00f3n completa. No <strong>ajuste<\/strong> agites. <\/p>\n<h3>Can SS-31 be stacked with NAD+ in studies?<\/h3>\n<p>Yes \u2014 this is a common multi-pathway mitochondrial studies combination. SS-31 stabilizes cristae architecture and cardiolipin-dependent ETC function; <a href=\"https:\/\/medsbase.com\/es\/nad\/\">NAD+<\/a> proporciona sustrato coenzim\u00e1tico para la cadena de transporte de electrones y la se\u00f1alizaci\u00f3n downstream de sirtuinas\/PARP. Los mecanismos son complementarios y no se solapan. <\/p>\n<h3>\u00bfQu\u00e9 concentraciones tiene MedsBase en stock?<\/h3>\n<p>MedsBase carries SS-31 (Elamipretide) in 5\u00a0mg, 10\u00a0mg, and 50\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis on request. <\/p>\n<h3>Does SS-31 cause side reported effects?<\/h3>\n<p>Published preclinical and clinical-trial has reported a favorable safety profile. Most commonly reported effects in the clinical-trial literature are injection-site reactions. Because SS-31 has been studied in multiple human trials (Phase 2 and Phase 3), its safety profile is better-characterised than most peptides. <\/p>\n<h3>\u00bfEs SS-31 lo mismo que Bendavia o Elamipretide?<\/h3>\n<p>S\u00ed. El mismo compuesto tiene tres nombres: <strong>SS-31<\/strong> (original Szeto-Schiller studies designation), <strong>Bendavia<\/strong> (nombre de desarrollo temprano de Stealth BioTherapeutics), y <strong>Elamipretide<\/strong> (international nonproprietary name \/ INN). Studies literature uses SS-31 predominantly; clinical-trial literature uses Elamipretide or Bendavia. <\/p>\n<h3>\u00bfCu\u00e1l es la vida media de SS-31?<\/h3>\n<p>SS-31 (elamipretide) tiene una vida media plasm\u00e1tica corta de aproximadamente 30-60 minutos tras la administraci\u00f3n subcut\u00e1nea, pero muestra una acumulaci\u00f3n mitocondrial prolongada debido a su afinidad por la cardiolipina en la membrana mitocondrial interna. La vida media en tejidos ricos en mitocondrias, como el m\u00fasculo card\u00edaco y esquel\u00e9tico, se estima en varias horas m\u00e1s all\u00e1 del aclaramiento plasm\u00e1tico. <\/p>\n<h3>\u00bfC\u00f3mo se dirige SS-31 espec\u00edficamente a las mitocondrias?<\/h3>\n<p>SS-31 es un p\u00e9ptido Szeto-Schiller con una estructura arom\u00e1tica-cati\u00f3nica alternante (D-Arg-dimetil-Tyr-Lys-Phe-NH\u2082). Esta secuencia impulsa la acumulaci\u00f3n en la membrana mitocondrial interna aproximadamente 1,000 veces por encima de los niveles citoplasm\u00e1ticos, mediada por la atracci\u00f3n electrost\u00e1tica al fosfol\u00edpido cardiolipina cargado negativamente. La uni\u00f3n a cardiolipina estabiliza los complejos de la cadena de transporte de electrones y reduce la producci\u00f3n de especies reactivas de ox\u00edgeno (ROS). <\/p>\n<h3>\u00bfPuedo pedir SS-31 para env\u00edo internacional?<\/h3>\n<p>S\u00ed. MedsBase env\u00eda SS-31 a todo el mundo desde nuestra red de env\u00edos dedicada a p\u00e9ptidos. Los pedidos que solo contienen p\u00e9ptidos califican para nuestro servicio de env\u00edo independiente de p\u00e9ptidos. Los pedidos se env\u00edan en embalaje con control de temperatura y seguimiento completo. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/es\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/es\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/es\/ipamorelin\/\"><strong>Ipamorelina<\/strong><\/a> \u2014 Agonista selectivo de grelina \u2014 pulso de GH limpio sin cortisol\/prolactina<\/li>\n<li><a href=\"\/es\/cjc-1295-with-dac\/\"><strong>CJC-1295 con DAC<\/strong><\/a> \u2014 An\u00e1logo de GHRH con vida media extendida<\/li>\n<li><a href=\"\/es\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Lecturas adicionales<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Lee nuestra gu\u00eda completa basada en evidencia: <a href=\"https:\/\/medsbase.com\/es\/ss-31-elamipretide-mitochondrial-guide\/\"><strong>SS-31 (Elamipretide) \u2014 cardiolipin targeting, mitochondrial studies &amp; clinical trials<\/strong><\/a>. Covers Szeto-Schiller mechanism studies, Stealth BioTherapeutics clinical development, cardiac\/renal\/neurological applications, and realistic context.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Mejora la energ\u00eda celular<br \/>\n\u2705 Supports mitochondrial function<br \/>\n\u2705 Reduce el estr\u00e9s oxidativo<br \/>\n\u2705 Mejora la resistencia de los tejidos<br \/>\n\u2705 Favorece la eficiencia metab\u00f3lica<\/p>\n<p><strong>SS-31<\/strong> contiene compuesto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":70982,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5476,5475],"class_list":["post-69029","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-elamipretide","product_tag-ss-31","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product\/69029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/comments?post=69029"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media\/70982"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media?parent=69029"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_brand?post=69029"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_cat?post=69029"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_tag?post=69029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}